Immunodeficient mice as models of human hematapoietic stem cell engraftment

Current Opinion in Immunology

Volumn 11, Issue 5, 1999, Pages 532-537

  Dao, Mo A ^a   Nolta, Jan A ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTEGRIN; VIRUS VECTOR;

CELL CYCLE; CELL TRANSPLANTATION; GENE THERAPY; HEMATOPOIETIC CELL; HUMAN; IMMUNE DEFICIENCY; LENTIVIRINAE; NONHUMAN; REVIEW; XENOTRANSPLANTATION;

EID: 0032849505     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(99)00006-0     Document Type: Review

References (49)

1. Cashman J, Bockhold K, Hogge DE, Eaves AC, Eaves CJ Sustained proliferation, multi-lineage differentiation and maintenance of primitive human haemopoietic cells in NOD/SCID mice transplanted with human cord blood. Br J Haematol. 98:1997;1026-1036.
2. Dick JE, Bhatia M, Gan O, Kapp U, Wang JC Assay of human stem cells by repopulation of NOD/SCID mice. Stem Cells. 15:1997;199-203.
3. Dao MA, Nolta JA Use of the bnx/hu xenograft model of human hematopoiesis to optimize methods for retroviral-mediated stem cell transduction. Int J Mol Med. 1:1998;257-264.
4. Bonnet D, Bhatia M, Wang JC, Kapp U, Dick JE Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice. Bone Marrow Transplant. 23:1999;203-209.
5. Greiner DL, Hesselton RA, Shultz LD SCID mouse models of human stem cell engraftment. Stem Cells. 16:1998;166-177.
6. Lapidot T, Fajerman Y, Kollet O Immune-deficient SCID and NOD/SCID mice models as functional assays for studying normal and malignant human hematopoiesis. J Mol Med. 75:1997;664-673.
7. Hogge DE, Ailles LE, Gerhard B Cytokine responsiveness of primitive progenitors in acute myelogenous leukemia. Leukemia. 11:1997;2220-2221.
8. Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med. 4:1998;1038-1045. The authors demonstrate the existence of a rare human stem-cell population that performs poorly in vitro but reconstitutes NOD/SCID mice. This stem cell lacks expression of the cell surface molecule CD34, previously thought to be present on all stem and progenitor cells.
9. De Wynter EA, Buck D, Hart C, Heywood R, Coutinho LH, Clayton A, Rafferty JA, Burt D, Guenechea G, Bueren JAet al. CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells. 16:1998;387-396.
10. Dao MA, Shah AJ, Crooks GM, Nolta JA Engraftment and retroviral marking of CD34+ and CD34+CD38- human hematopoietic progenitors assessed in immune-deficient mice. Blood. 91:1998;1243-1255.
11. Bhatia M, Bonnet D, Kapp U, Wang JC, Murdoch B, Dick JE Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med. 186:1997;619-624.
12. Berardi AC, Meffre E, Pflumio F, Katz A, Vainchenker W, Schiff C, Coulombel L Individual CD34+CD38lowCD19-CD10-progenitor cells from human cord blood generate B lymphocytes and granulocytes. Blood. 89:1997;3554-3564.
13. Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, Byk T, Nagler A, Ben-Hur H, Many A, Shultz Let al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science. 283:1999;845-848. Treatment of a human hematopoietic stem cell inoculum with antibodies to the SDF-1 receptor, CXCR4, blocked engraftment of the cells in NOD/SCID mice. Treatment with SCF and IL-6, which upregulate CXCR4, augmented engraftment.
14. Van der Loo JC, Xiao X, McMillin D, Hashino K, Kato I, Williams DA VLA-5 is expressed by mouse and human long-term repopulating hematopoietic cells and mediates adhesion to extracellular matrix protein fibronectin. J Clin Invest. 102:1998;1051-1061.
15. Dao MA, Hashino K, Kato I, Nolta JA Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells. Blood. 92:1998;4612-4621. Culture of human bone-marrow-derived stem and progenitor cells in suspension culture with serum and cytokines significantly reduced their capacity for hematopoietic reconstitution. If the same cells were cultured in the same conditions but on the carboxy-terminal fragment of fibronectin, they retained the capacity for long-term hematopoiesis.
16. Nolta JA, Kohn DB: Retroviral-mediated transduction of human hematopoietic stem cells. In Current Protocols in Human Genetics, vol 13. Edited by Boyle A. Chichester, UK: John Wiley and Sons; 1997:unit 13.7.
17. Van der Loo JC, Hanenberg H, Cooper RJ, Luo FY, Lazaridis EN, Williams DA Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells. Blood. 92:1998;2556-2570.
18. Kamel-Reid S, Dick JE Engraftment of immune-deficient mice with human hematopoietic stem cells. Science. 242:1988;1706-1712.
19. Nolta JA, Hanley MB, Kohn DB Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors. Blood. 83:1994;3041-3051.
20. Brouard N, Chapel A, Neildez-Nguyen TMM, Granotier C, Khazaal I, Peault B, Thierry D Transplantation of stromal cells transduced with the human IL3 gene to stimulate hematopoiesis in human fetal bone grafts in non-obese, diabetic-severe combined immunodeficiency mice. Leukemia. 12:1998;1128-1135.
21. Cashman JD, Eaves CJ Human growth factor-enhanced regeneration of transplantable human hematopoietic stem cells in nonobese diabetic/severe combined immunodeficient mice. Blood. 93:1999;481-487. The authors report that administration of human SCF, IL-3, GM-CSF and erythropoietin to human cord NOD/SCID mice engrafted with human cord blood for the 14 days prior to harvest results in a ten-fold increase in the number of re-transplantable human lymphomyeloid repopulating cells.
22. Dao MA, Pepper KA, Nolta JA Long-term cytokine production from engineered primary human stromal cells influences human hematopoiesis in an in vivo xenograft model. Stem Cells. 15:1997;443-454.
23. Kapp U, Bhatia M, Bonnet D, Murdoch B, Dick JE Treatment of non-obese diabetic (NOD)/severe-combined immunodeficient mice (SCID) with flt3 ligand and interleukin-7 impairs the B-lineage commitment of repopulating cells after transplantation of human hematopoietic cells. Blood. 92:1998;2024-2031.
24. Guenechea G, Segovia JC, Albella B, Lamana M, Ramirez M, Regidor C, Fernandez MN, Bueren JA Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells. Blood. 93:1999;1097-1105.
25. Conneally E, Cashman J, Petzer A, Eaves C Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci USA. 94:1997;9836-9841.
26. 1 phase - using the methods described in this paper - did not force the cells into differentiation, as measured in the bnx-hu xenograft system.
27. Eaves CJ, Cashman JD, Kay RJ, Dougherty GJ, Otsuka T, Gaboury LA, Hogge DE, Lansdorp PM, Eaves AC, Humphries RK Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood. 78:1991;110-117.
28. Dao MA, Hannum CH, Kohn DB, Nolta JA FLT3 ligand preserves the ability of human CD34+ progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction. Blood. 89:1997;446-456.
29. Bhatia M, Bonnet D, Wu D, Murdoch B, Wrana J, Gallacher L, Dick JE Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells. J Exp Med. 189:1999;1139-1148.
30. Kohn DB, Hershfield MS, Carbonaro D, Shigeoka A, Brooks J, Smogorzewska EM, Barsky LW, Chan R, Burotto F, Annett Get al. T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nat Med. 4:1998;775-780.
31. Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, el-Khoureiy Aet al. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nat Med. 1:1995;1017-1023.
32. Hanley ME, Nolta JA, Parkman R, Kohn DB Umbilical cord blood cell transduction by retroviral vectors: preclinical studies to optimize gene transfer. Blood Cells. 20:1994;539-543.
33. Conneally E, Eaves CJ, Humphries RK Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential. Blood. 91:1998;3487-3493.
34. Levesque JP, Haylock DN, Simmons PJ Cytokine regulation of proliferation and cell adhesion are correlated events in human CD34+ hemopoietic progenitors. Blood. 88:1996;1168-1176.
35. Saeland S, Duvert V, Caux C, Pandrau D, Favre C, Valle A, Durand I, Charbord P, de Vries J, Banchereau J Distribution of surface-membrane molecules on bone marrow and cord blood CD34+ hematopoietic cells. Exp Hematol. 20:1992;24-33.
36. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 272:1996;263-267.
37. Miyoshi H, Smith KA, Mosier DE, Verma IM, Torbett BE Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science. 283:1999;682-686. The authors demonstrate that lentiviral vectors, based on HIV-1, can mediate transduction of a significant portion of NOD/SCID-engrafting cells from human cord blood in the absence of cytokine stimulation.
38. Case SS, Price MA, Jordan CT, Yu XJ, Wang L, Bauer G, Haas DL, Xu D, Stripecke R, Naldini Let al. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci USA. 96:1999;2988-2993.
39. Gothot A, van der Loo JC, Clapp DW, Srour EF Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. Blood. 92:1998;2641-2649. The authors demonstrate that hematopoietic stem cells that have been driven out of their quiescent state into cell cycle do not engraft as well as resting stem cells. Discussion of these findings, and their implications, is provided in the text of the review.
40. Hendrikx PJ, Martens CM, Hagenbeek A, Keij JF, Visser JW Homing of fluorescently labeled murine hematopoietic stem cells. Exp Hematol. 24:1996;129-140.
41. Nolta JA, Smogorzewska EM, Kohn DB Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood. 86:1995;101-110.
42. Becker PS, Nilsson SK, Li Z, Berrios VM, Dooner MS, Cooper CL, Hsieh CC, Quesenberry PJ Adhesion receptor expression by hematopoietic cell lines and murine progenitors: modulation by cytokines and cell cycle status. Exp Hematol. 27:1999;533-541. Cells cultured in suspension with cytokines have reduced expression of VLA-4 and other integrins. The reduction in integrin levels correlated with poor engraftment.
43. Papayannopoulou T, Craddock C Homing and trafficking of hemopoietic progenitor cells. Acta Haematol. 97:1997;97-104.
44. Papayannopoulou T, Craddock C, Nakamoto B, Priestley GV, Wolf NS The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen. Proc Natl Acad Sci USA. 92:1995;9647-9651.
45. Spence SE, Keller JR, Ruscetti FW, McCauslin CS, Gooya JM, Funakoshi S, Longo DL, Murphy WJ Engraftment of ex vivo expanded and cycling human cord blood hematopoietic progenitor cells in SCID mice. Exp Hematol. 26:1998;507-514.
46. Van Hennik PB, Verstegen MM, Bierhuizen MF, Limon A, Wognum AW, Cancelas JA, Barquinero J, Ploemacher RE, Wagemaker G Highly efficient transduction of the green fluorescent protein gene in human umbilical cord blood stem cells capable of cobblestone formation in long-term cultures and multilineage engraftment of immunodeficient mice. Blood. 92:1998;4013-4022. The authors used the EGFP marker, detectable by FACS (flow-assisted cell sorting), to optimize vector promoters and transduction conditions that allow transgene expression in multilineage progeny of human umbilical cord blood progenitors in NOD/SCID mice.
47. Verlinden SF, van Es HH, van Bekkum DW Serial bone marrow sampling for long-term follow up of human hematopoiesis in NOD/SCID mice. Exp Hematol. 26:1998;627-630. The authors describe a method for collection of bone marrow samples from mice that does not require sacrificing the animals. Therefore serial analyses can be done on the same transplanted human hematopoietic cell populations.
48. Nolta JA, Dao MA, Wells S, Smogorzewska EM, Kohn DB Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. Proc Natl Acad Sci USA. 93:1996;2414-2419.
49. Dao MA, Yu XJ, Nolta JA Clonal diversity of primitive human hematopoietic progenitors following retroviral marking and long-term engraftment in immune-deficient mice. Exp Hematol. 25:1997;1357-1366.